Further Insights Into Anticholinergic Action Informed by Japanese Anticholinergic Risk Scale
Geriatrics & Gerontology International · 2026-01 · 26 (1)
DOI: 10.1111/ggi.70278 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Geriatrics & Gerontology International, online erschienen am 03.12.2025. Verfasst von Masaki Mogi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Ehime University, Graduate School of Medicine, Shitsukawa, Tohon, Ehime, Japan. Hauptthemen laut MEDLINE: Cholinergic Antagonists. Die Arbeit nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
The increased anticholinergic burden caused by medications in older adults is one of the adverse drug reactions of particular concern, as it can exacerbate the onset of geriatric syndromes or induce cognitive dysfunction, and is also related to the issue of polypharmacy. One year has passed since the “Japanese Anticholinergic Risk Scale” was published by the Japanese Society of Geriatric Pharmacy, and the anticholinergic effects of various medications have garnered attention. These medications are used in clinical practice and research. The anticholinergic effects of drugs are not necessarily induced solely by binding to muscarinic receptors and exerting antagonistic actions but may also occur as a result of various combined effects. In this review, we focus on drugs that show differences between the “Yamada Classification,” which was created based on in vitro muscarinic receptor binding activity, and the “Japanese Anticholinergic Risk Scale.” We re‐examine anticholinergic effects and, through a review of the literature, identify drugs that induce “anticholinergic‐like effects” beyond direct muscarinic receptor antagonism. By understanding the potential mechanisms underlying “anticholinergic‐like effects” in drugs where anticholinergic effects listed in the risk scale are not anticipated, we aim to reemphasize the prevalence of drugs with anticholinergic‐like effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Ehime University, Graduate School of Medicine, Shitsukawa, Tohon, Ehime, Japan.
- Department of Anesthesiology, Saiseikai Matsuyama Hospital, Matsuyama, Ehime, Japan.
- Research Division, Saiseikai Research Institute of Health Care and Welfare, Tokyo, Japan.
- Center for Pharmacist Education, School of Pharmacology, Nihon University, Chiba, Japan.
- Center for Pharma-Food Research (CPFR), Graduate School of Pharmaceutical Science, University of Shizuoka, Shizuoka, Japan.
ORCID-Profile: Shuang Liu, Shizuo Yamada
Zitieren
APA
Mogi, M., Liu, S., Suzuki, Y., Shibata, Y., & Yamada, S. (2026). Further Insights Into Anticholinergic Action Informed by Japanese Anticholinergic Risk Scale. Geriatrics & Gerontology International, 26(1). https://doi.org/10.1111/ggi.70278
Vancouver
Mogi M, Liu S, Suzuki Y, Shibata Y, Yamada S. Further Insights Into Anticholinergic Action Informed by Japanese Anticholinergic Risk Scale. Geriatrics & Gerontology International. 2026;26(1). doi:10.1111/ggi.70278
BibTeX
@article{Mogi2026,
author = {Mogi, Masaki and Liu, Shuang and Suzuki, Yasuyuki and Shibata, Yuuka and Yamada, Shizuo},
title = {Further Insights Into Anticholinergic Action Informed by Japanese Anticholinergic Risk Scale},
journal = {Geriatrics & Gerontology International},
year = {2026},
volume = {26},
number = {1},
doi = {10.1111/ggi.70278}
}
EUVIMED